A carregar...
New investigational drugs with single-agent activity in multiple myeloma
The treatment of multiple myeloma (MM) is rapidly evolving. In the United States, four drugs (panobinostat, ixazomib, daratumumab and elotuzumab) were approved for the treatment of MM in 2015. As a result of improved diagnosis and therapy, there has been a dramatic improvement in the outcome of MM i...
Na minha lista:
| Publicado no: | Blood Cancer J |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Nature Publishing Group
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5030378/ https://ncbi.nlm.nih.gov/pubmed/27471867 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bcj.2016.53 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|